ARTICLE | Company News
Amylin, Restoragen deal
January 6, 2003 8:00 AM UTC
AMLN acquired from Restoragen rights to a continuous infusion formulation of glucagon-like peptide 1 (GLP-1), which is in Phase II testing to treat congestive heart failure (CHF) patients who are inel...